Rynazma Syrup 60 ml belongs to the class of drugs called 'bronchodilators' primarily used to prevent and treat symptoms of asthma and chronic obstructive pulmonary disease (COPD). Asthma is a chronic (long-term) respiratory condition in which airways narrow, swell, and produce extra mucus, leading to difficulty in breathing. COPD is a group of lung diseases with emphysema (shortness of breath) and chronic bronchitis (inflammation of the lining of bronchial tubes).
Rynazma Syrup 60 ml contains Doxofylline that acts by inhibiting the phosphodiesterase 4 (PD-4) thereby relaxing the bronchial smooth muscle of lung's airways, making it easier for asthma and COPD patient to breath easily.
Use Rynazma Syrup 60 ml as prescribed. Your doctor will recommend you how often you take Rynazma Syrup 60 ml based on your medical condition. Some people may experience headache, nausea, vomiting, stomach pain, irritability, insomnia (difficulty in falling or staying asleep) or fast heart rate. Most of these side effects of Rynazma Syrup 60 ml do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.
Rynazma Syrup 60 ml is contraindicated in acute myocardial infarction, low blood pressure (hypotension), lactating women and patients allergic to Rynazma Syrup 60 ml. Let your doctor know if you are pregnant or planning for pregnancy, before using Rynazma Syrup 60 ml. Rynazma Syrup 60 ml should be used with caution in congestive heart failure patients as these patients have slow drug clearance leading to high blood levels even after stopping treatment with Rynazma Syrup 60 ml.